ArticleEuropean clinical respiratory journal2026
Mapping heterogeneity in the management of malignant pleural effusions with indwelling pleural catheters in Denmark - a national survey.
Article in European clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant pleural effusion (MPE) affects up to 20% of cancer patients, causing dyspnea and frequent hospitalizations. Treatment includes thoracentesis, pleurodesis, and indwelling pleural catheters (IPC). While UK pleural clinics enhance outpatient care, Denmark lacks a national strategy. This study aims to map the use of IPCs in a Nordic country, focusing on referral, placement, follow-up, and reimbursement of expenses to drainage supplies. Methods: A national questionnaire survey was conducted from January to July 2022. The questionnaire, developed by the Danish Respiratory Society's pleural diseases group, covered IPC placement, management, follow-up, and financial aspects. It was distributed to all departments placing IPCs, identified via suppliers and expert input. Data on the number of IPCs delivered to each department in 2022 were obtained from Danish IPC retailers. Results: Of the 23 identified departments, 20 completed the survey. IPCs were available in all five Danish healthcare regions, but heterogeneity was observed in prevalence, reimbursement methods, procedural organization, and follow-up strategies. IPC use was more prevalent in respiratory medical departments and in the North and Central Regions. No standardized national reimbursement policy was identified. Conclusion: This survey reveals regional disparities in IPC use and reimbursement in Denmark within the same public healthcare system. The lack of national guidelines and centralized funding mechanisms may contribute to these variations. The introduction of dedicated pleural clinics and standardized reimbursement policies could help ensure equitable and guideline-based MPE management across regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.